Centerpiece
Latest Headlines
Quote
Spotlight
Click for Full Story Mylan does a deal, drops

Generic drugmaker Mylan agreed to buy Meda AB of Sweden for $7.2 billion in cash and stock, aiming to enter new markets including China and Russia and gaining more over-the-counter products.

  1 
Read Story Feb. 12, 2016



AP Privacy Policy | AP Terms of Use